HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chen-Chung Chu Selected Research

HLA-DR11 antigen

10/2015Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chen-Chung Chu Research Topics

Disease

4Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
09/2008 - 01/2007
3Hepatitis B
10/2019 - 10/2013
3Autoimmune Diseases (Autoimmune Disease)
10/2015 - 02/2013
3Infections
10/2013 - 09/2003
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020 - 01/2018
2Neoplasms (Cancer)
02/2010 - 03/2007
2Genetic Predisposition to Disease (Genetic Predisposition)
04/2007 - 03/2005
2Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2007 - 04/2006
1Celiac Disease (Celiac Sprue)
01/2020
1Hypersensitivity (Allergy)
10/2015
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2015
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2015
1Glomerulonephritis
10/2015
1IGA Glomerulonephritis (IGA Nephropathy)
10/2015
1Chronic Kidney Failure (Chronic Renal Failure)
10/2015
1Graves Disease (Basedow Disease)
07/2015
1Agranulocytosis (Granulocytopenia)
07/2015
1Varicella Zoster Virus Infection
02/2013
1Multibacillary Leprosy
07/2010
1Leprosy (Hansen's Disease)
07/2010
1Neutropenia
05/2009
1Rheumatoid Arthritis
04/2007
1Severe Acute Respiratory Syndrome
05/2006
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2006
1Carcinogenesis
04/2006
1Drug Hypersensitivity Syndrome
03/2005
1Gout
03/2005
1Cicatrix (Scar)
03/2005
1Stevens-Johnson Syndrome (Lyell's Syndrome)
03/2005
1Hyperuricemia
03/2005
1Communicable Diseases (Infectious Diseases)
09/2003

Drug/Important Bio-Agent (IBA)

9HLA Antigens (Human Leukocyte Antigens)IBA
01/2020 - 09/2003
4HLA-DRB1 Chains (HLA DRB1)IBA
02/2013 - 04/2006
3AntigensIBA
10/2015 - 03/2007
3HLA-A Antigens (HLA-A)IBA
10/2015 - 03/2007
3HLA-B Antigens (HLA-B)IBA
07/2010 - 09/2003
3Immunologic Factors (Immunomodulators)IBA
09/2008 - 01/2007
2HLA-DQ Antigens (HLA-DQ)IBA
01/2020 - 05/2009
2AntibodiesIBA
01/2020 - 05/2009
2HLA-DPB1 antigen (HLA DPB1)IBA
05/2015 - 10/2013
2AutoantibodiesIBA
02/2013 - 05/2009
2HLA-DQB1 antigen (HLA DQB1)IBA
02/2013 - 05/2009
2Proteins (Proteins, Gene)FDA Link
03/2007 - 05/2006
2Peptides (Polypeptides)IBA
03/2007 - 03/2005
2HLA-A*02:01 antigenIBA
03/2007 - 05/2006
1HLA-DQ8 antigenIBA
01/2020
1Protein Glutamine gamma Glutamyltransferase 2IBA
01/2020
1HLA-DPA1 antigen (HLA DPA1)IBA
10/2019
1HLA-DR11 antigenIBA
10/2015
1HLA-DR3 Antigen (HLA DR3 Antigen)IBA
10/2015
1Antithyroid Agents (Antithyroid Drugs)IBA
07/2015
1HLA-DP Antigens (HLA-DP)IBA
10/2013
1HLA-DRB1*04:05 antigenIBA
07/2010
1Interleukin-7 (Interleukin 7)IBA
02/2010
1Interleukin-6 (Interleukin 6)IBA
02/2010
1CytokinesIBA
02/2010
1HLA-DR Antigens (HLA-DR)IBA
05/2009
1CD40 Ligand (CD40L)IBA
09/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2008
1Interleukin-4 (Interleukin 4)IBA
01/2008
1EpitopesIBA
04/2007
1Biomarkers (Surrogate Marker)IBA
04/2007
1HLA-A11 AntigenIBA
03/2007
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
05/2006
1Genetic Markers (Genetic Marker)IBA
03/2005
1Pharmaceutical PreparationsIBA
03/2005
1Allopurinol (Remid)FDA LinkGeneric
03/2005
1MutS ProteinsIBA
03/2005
1HLA-B*46:01 antigenIBA
09/2003

Therapy/Procedure

1Immunotherapy
02/2010